What Happens at Your First IBD Follow-Up Appointment?
By the Aidy Editorial Team
First Published Jun 28, 2026Last Updated Jul 23, 2026
Your first follow-up appointment after an inflammatory bowel disease diagnosis is where the plan set at diagnosis gets tested against real life. The diagnostic workup answered whether you have Crohn's disease or ulcerative colitis and where the inflammation sits. This visit answers a different question: is the treatment working, and what needs to change? Knowing what your gastroenterologist will review, which tests may be ordered, and how to arrive with organized symptom, medication, and test-result context turns a rushed twenty minutes into a productive conversation. Here is what to expect at a first IBD follow-up appointment and how to prepare for it.
Why the First Follow-Up Visit Matters
Modern IBD care follows a strategy called treat-to-target, formalized in the international STRIDE-II consensus, which sets defined goals for treatment and checks progress against them at regular intervals. Those targets are grouped into a short-term goal of clinical response, an intermediate goal of normalizing laboratory markers such as C-reactive protein and fecal calprotectin, and a long-term goal of healing visible on endoscopy or imaging. The follow-up appointment is the checkpoint where your care team measures where you sit against these targets. The broader aim of medication, as the National Institute of Diabetes and Digestive and Kidney Diseases describes, is to lower inflammation, prevent flares, and keep you in remission. Your first visit begins the loop of measuring, adjusting, and re-checking that defines ongoing IBD management.
What Your Gastroenterologist Will Review
Expect the conversation to open with your symptoms since diagnosis. Your gastroenterologist will want specifics: how many bowel movements a day, whether there is blood, urgency, abdominal pain, fatigue, weight change, and any symptoms outside the gut such as joint pain or eye irritation. The Crohn's & Colitis Foundation encourages patients to learn to recognize the difference between a flare and remission and to track that pattern between visits. Your clinician will also review how you are tolerating your medication, whether you have taken it as prescribed, and whether side effects have appeared. A clear, dated account of what has happened since diagnosis, rather than a general sense that things are "better" or "worse," gives the appointment a factual foundation and helps your team judge whether you are moving toward the treatment target.
The Tests That May Be Ordered
Objective testing is central to a follow-up visit because symptoms alone can understate or overstate the inflammation present. Blood tests commonly check for anemia and for C-reactive protein, which rises when there is inflammation in the body. A stool test for fecal calprotectin is a frequent tool: it measures a protein released during intestinal inflammation and helps show whether IBD is getting better or worse. The Crohn's & Colitis Foundation notes that specific biomarker levels are often followed over time to confirm the therapy is optimized, and that endoscopy can be repeated to check for mucosal healing. Not every test happens at every visit; your gastroenterologist chooses based on how you are doing and how long you have been on treatment.
Medication Review and Adjustments
A first follow-up often includes decisions about your drug regimen. If you started a corticosteroid to control early symptoms, expect a plan to taper it, since steroids are meant for short-term use only and are not a maintenance therapy. If you are on a biologic and your symptoms or markers suggest the drug is not fully controlling disease, your clinician may use blood testing to guide the next step. The American Gastroenterological Association suggests reactive therapeutic drug monitoring, measuring drug and antibody levels, to guide changes when a patient on an anti-TNF biologic has active disease. For those starting a thiopurine such as azathioprine, the same guideline suggests routine thiopurine methyltransferase testing to direct safe dosing. Even in milder disease, the American College of Gastroenterology advises clinicians to regularly monitor for active inflammation using objective measures rather than relying on how you feel alone.
Preventive Care and Health Maintenance
IBD follow-up extends beyond the gut, because many treatments suppress the immune system and raise other health risks. The American College of Gastroenterology's preventive care guidance recommends that IBD patients on immunosuppressive therapy stay current on vaccines, including the inactivated influenza vaccine rather than the live nasal version, and pneumococcal vaccination. The same guidance calls for annual cervical cancer screening in women on immunosuppression, skin cancer screening for patients on thiopurines, periodic bone mineral density testing in those with risk factors, and screening for depression and anxiety in patients with IBD. Your first follow-up is a natural moment to confirm these preventive steps are on the calendar, because they are easy to overlook once attention focuses on symptoms and medication.
How to Prepare and What to Bring
Preparation is what separates a wasted appointment from a useful one. Bring a written, dated symptom log, a current list of all medications and doses including over-the-counter products, and copies or dates of any recent lab or imaging results. The Crohn's & Colitis Foundation recommends bringing writing materials to note down terms and instructions, and asking how best to contact your care team between appointments with follow-up questions. Prepare a short list of your top questions in advance so the most important ones get answered first. Useful questions include what your current test results mean, what the treatment target is for you specifically, what side effects should prompt a call, and when the next appointment and next round of testing should happen.
Arriving with an organized summary of everything that has happened since diagnosis is the single change that most improves a first IBD follow-up. It lets your gastroenterologist spend the visit interpreting your situation and adjusting your plan instead of reconstructing a timeline from memory. Treat this appointment as the first turn of an ongoing cycle of measuring inflammation, reviewing medication, and confirming preventive care, and each subsequent visit becomes easier to navigate.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.
Your Personal IBD Baseline: The Eight Things to Record When You Feel Well ›